MetLife Investment Management LLC Has $5.13 Million Stake in Maximus, Inc. (NYSE:MMS)

MetLife Investment Management LLC grew its position in Maximus, Inc. (NYSE:MMS - Free Report) by 6.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 68,689 shares of the health services provider's stock after purchasing an additional 4,219 shares during the period. MetLife Investment Management LLC owned about 0.12% of Maximus worth $5,128,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MMS. Norges Bank bought a new position in Maximus during the fourth quarter worth about $71,443,000. Federated Hermes Inc. grew its position in shares of Maximus by 74.8% in the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock valued at $65,912,000 after purchasing an additional 377,705 shares during the period. Marshall Wace LLP increased its stake in Maximus by 1,319.1% during the 4th quarter. Marshall Wace LLP now owns 224,267 shares of the health services provider's stock worth $16,742,000 after purchasing an additional 208,463 shares in the last quarter. Vanguard Group Inc. raised its holdings in Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after buying an additional 205,564 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in Maximus by 14.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after buying an additional 177,075 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Price Performance

Shares of NYSE MMS opened at $68.33 on Thursday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The business has a 50-day moving average of $67.63 and a 200-day moving average of $74.92. The stock has a market capitalization of $3.87 billion, a price-to-earnings ratio of 14.69 and a beta of 0.68. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, sell-side analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. Maximus's dividend payout ratio is presently 25.81%.

Insider Activity at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

MMS has been the subject of several research reports. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.